W Shelley

A randomized trial of maintenance versus no maintenance melphalan and prednisone in responding multiple myeloma patients

Andrew R. Belch, W Shelley, Daniel E. Bergsagel et al. · British Journal of Cancer · 1988 · 159 citations · Full text

Medicine, Oncology, Pharmacology +17

Canadian multicenter randomized trial comparing sequential and alternating administration of two non-cross-resistant chemotherapy combinations in patients with limited small-cell carcinoma of the lung.

Ronald Feld, William K. Evans, P. Coy et al. · Journal of Clinical Oncology · 1987 · 142 citations

Medicine, Oncology, Pharmacology +15

Improved survival in patients with poor-prognosis malignant melanoma treated with adjuvant levamisole: a phase III study by the National Cancer Institute of Canada Clinical Trials Group.

Ian Quirt, W Shelley, Joe Pater et al. · Journal of Clinical Oncology · 1991 · 80 citations

Pharmacy, Oncology, Pharmacotherapy +16

Toxicity of abdominopelvic radiation in advanced ovarian carcinoma patients after cisplatin/cyclophosphamide therapy and second-look laparotomy.

W Shelley, A A Starreveld, JA Carmichael et al. · PubMed · 1988 · 21 citations

Medicine, Oncology, Radiation Oncology +17

Weekly cyclophosphamide and alternate-day prednisone: an effective secondary therapy in multiple myeloma.

Kenneth S. Wilson, W Shelley, Andrew R. Belch et al. · PubMed · 1987 · 10 citations

Medicine, Pharmacology, Pharmacotherapy +13